Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Genes & Development|December 3, 2010
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNASyuzo Kaneko, Gang Li, Jinsook Son, et al.Molecular Cell|December 31, 2013
Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatinSyuzo Kaneko, Roberto Bonasio, Ricardo Saldaña-Meyer, et al.JCI Insight|February 15, 2022
Notch-mediated Ephrin signaling disrupts islet architecture and β cell functionAlberto Bartolomé, Nina Suda, Junjie Yu, et al.Molecular Metabolism|February 4, 2024
β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese miceNina Suda, Alberto Bartolomé, Jiani Liang, et al.Diabetology International|January 13, 2023
Reflections on the state of diabetes research and prospects for treatmentDomenico Accili, Wen Du, Takumi Kitamoto, et al.Cell|October 2, 2012
Asymmetrically modified nucleosomesPhilipp Voigt, Gary LeRoy, William J Drury, et al.Biorxiv : the Preprint Server for Biology|February 20, 2025
Fatty Acid Transport Protein-2 (FATP2) Inhibition Enhances Glucose Tolerance through α-Cell-mediated GLP-1 SecretionShenaz Khan, Robert J Gaivin, Zhiyu Liu, et al.The Journal of Clinical Investigation|September 16, 2025
Fatty acid transport protein 2 inhibition enhances glucose tolerance through α cell-mediated GLP-1 secretionShenaz Khan, Robert J Gaivin, Zhiyu Liu, et al.Science Translational Medicine|February 1, 2023
Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetesHitoshi Watanabe, Wen Du, Jinsook Son, et al.The Journal of Clinical Investigation|December 15, 2021
BACH2 inhibition reverses β cell failure in type 2 diabetes modelsJinsook Son, Hongxu Ding, Thomas B Farb, et al.Pageof 3